Sanofi-Synthelabo Group achieved 15% of sales up last year.

Sanofi-Synthelabo group reported their business performances during 2003 on Feb. 17 describing, to compare to the previous year, 15.6% up of the net sales with 8,048 million Euro dollars (about 11 trillion won), 17.6% up of the ordinary profits, 17.7% up of the net profits with 2,069 million Euro dollars (3,580 billion won) and 8.0% up of the R&D.

Sanofi said that the clinical phase III stu...